Eliem Therapeutics, Inc. Company Information
Eliem Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Eliem Therapeutics, Inc.
- Ticker: ELYM
- Exchange: NasdaqGM
- Founded: 2018
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$127.877m
- Shares Outstanding: 28.04m
- Website: https://eliemtx.com
Number of Employees
Location
- Eliem Therapeutics, Inc.
- 23515 NE Novelty Hill Road
- Suite B221 #125
- Redmond
- Washington
- 98053
- United States
Listings
Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
---|---|---|---|---|---|---|
ELYM | NasdaqGM (Nasdaq Global Market) | Yes | Common Stock | US | USD | Aug 2021 |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/17 00:00 |
End of Day Share Price | 2024/04/15 00:00 |
Earnings | 2023/12/31 |
Annual Earnings | 2023/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.